EMBO Molecular Medicine (Feb 2024)
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
- Christopher W Schultz,
- Yang Zhang,
- Rajaa Elmeskini,
- Astrid Zimmermann,
- Haiqing Fu,
- Yasuhisa Murai,
- Darawalee Wangsa,
- Suresh Kumar,
- Nobuyuki Takahashi,
- Devon Atkinson,
- Liton Kumar Saha,
- Chien-Fei Lee,
- Brian Elenbaas,
- Parth Desai,
- Robin Sebastian,
- Ajit Kumar Sharma,
- Melissa Abel,
- Brett Schroeder,
- Manan Krishnamurthy,
- Laurel L Bassel,
- Rajesh Kumar,
- Nitin Roper,
- Mirit Aladjem,
- Frank T Zenke,
- Zoe Weaver Ohler,
- Yves Pommier,
- Anish Thomas
Affiliations
- Christopher W Schultz
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Yang Zhang
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Rajaa Elmeskini
- Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research
- Astrid Zimmermann
- Merck KGaA, Biopharma R&D, Translational Innovation Platform Oncology
- Haiqing Fu
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Yasuhisa Murai
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Darawalee Wangsa
- Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Suresh Kumar
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Nobuyuki Takahashi
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Devon Atkinson
- Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research
- Liton Kumar Saha
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Chien-Fei Lee
- EMD Serono Research and Development Institute Inc., Biopharma R&D, Translational Innovation Platform Oncology
- Brian Elenbaas
- EMD Serono Research and Development Institute Inc., Biopharma R&D, Translational Innovation Platform Oncology
- Parth Desai
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Robin Sebastian
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Ajit Kumar Sharma
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Melissa Abel
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Brett Schroeder
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Manan Krishnamurthy
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Laurel L Bassel
- Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research
- Rajesh Kumar
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Nitin Roper
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Mirit Aladjem
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Frank T Zenke
- Merck KGaA, Biopharma R&D, Translational Innovation Platform Oncology
- Zoe Weaver Ohler
- Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research
- Yves Pommier
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Anish Thomas
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- DOI
- https://doi.org/10.1038/s44321-024-00029-x
- Journal volume & issue
-
Vol. 16,
no. 3
pp. 664 – 664
Abstract
No abstracts available.